Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ <p>The Iranian Red Crescent Medical Journal (IR<span style="color: #ff0000;">C</span>MJ) is an international, open access, peer-reviewed, monthly, and ISI- Journal, affiliated to&nbsp;<strong>Iranian Hospital- Dubai</strong>, publishes original scientific studies in English that have direct clinical significance on&nbsp;<span style="color: #0033ff;">Basic Science, Clinical Medicine, Humanitarian Assistance, Trauma, and Disaster Management</span>.&nbsp;The journal strives to strengthen connections between research and practice, so enhancing professional development and improving practice within the field of medicine. Original papers submitted to this journal which do not adhere to the Instructions for Authors will be returned for appropriate revision to be in line with the Instructions for Authors. They may then be re-submitted.</p> en-US publisher@ircmj.org (Ahmad Soltani MD, PhD) publisher@ircmj.org (N. Gonabadi) Tue, 14 Sep 2021 00:00:00 +0430 OJS 3.3.0.7 http://blogs.law.harvard.edu/tech/rss 60 Fabrication of a Maxillofacial Prosthesis with A Novel Suspension Technique for a Patient with Exenteration: A Case Report https://ircmj.com/index.php/IRCMJ/article/view/895 <p><strong>Introduction:</strong> Fabrication of a prosthesis for people who lose an eye and parts of their cheekbones and nasal tissues is a challenge. The prosthesis suspension is a significant problem due to the open nasal cavity and the vast lesion area on the face.</p> <p><strong>Case Presentation:</strong> The present case report describes the application of a new suspension technique for a maxillofacial prosthesis on a person with an exenterated left eye. Moreover, parts of the patient’s maxillary and frontal sinuses had been as well removed due to infection. The conventional methods for suspending the prosthesis (i.e., anatomical, mechanical, chemical, and surgical methods) could not be used due to the fact that the patient’s sinus and nasal cavities were exposed. Therefore, a new prosthetic suspension technique was used to solve this problem.</p> <p><strong>Conclusion: </strong>In this clinical report, an optimal and effective method was adopted to make a prosthesis that can be used in similar cases of eye loss and extensive loss of the face. This new method does not need the application of adhesives and minimizes the donning and doffing time of the prosthesis.</p> Alireza Khaghani, Taher Babaee, Shahla Mohajeri, Naeimeh Rouhani Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/895 Tue, 14 Sep 2021 00:00:00 +0430 Complete atrioventricular block complicated with cardiogenic shock as primary presentation of novel coronavirus infection in a child; A rare case report https://ircmj.com/index.php/IRCMJ/article/view/672 <p><strong>Abstract:</strong></p> <p>Since late 2019, the outbreak of COVID-19 has rapidly spread worldwide. Due to the novelty unknown of this disease, manyof its manifestations are in an aura of ambiguity. We describe a Cardiac involvement of this disease that presented with a complete atrioventricular block in a child.</p> Feisal Rahimpour, Mohsen Yaghubi, Reza Ghasemi, MAHMOOD hosseinzadeh maleki Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/672 Tue, 14 Sep 2021 00:00:00 +0430 Telehealth and Telemedicine in response to selected critical coronavirus: A systematic review https://ircmj.com/index.php/IRCMJ/article/view/1150 <p>Abstract</p> <p><strong>Background &amp; Objectives:</strong> Due to the outbreak of COVID-19, applying telehealth and telemedicine to prevent the spread of disease is inevitable. Therefore, this study aimed to investigate the application of telehealth and telemedicine in the human coronavirus epidemic.</p> <p><strong>Materials and Methods:</strong> The systematic search was conducted in Medline (through PubMed), Scopus, and ISI Web of Science to identify relevant studies published until June 10, 2020. Inclusion criteria included studies in which telemedicine and telehealth were utilized as healthcare services in COVID-19, SARS, or MERS epidemics. This review was performed according to PRISMA guidelines.</p> <p><strong>Results:</strong> A total of 598 articles were identified after removing duplicates. After the systematic screening, 18 studies were met our criteria. The analysis showed that only one study was related to SARS, and the rest were on COVID-19 disease. Teleconsultation and televisit had a high percentage (55.6%) among other types of telemedicine services. The most mentioned obstacles were access to suitable technologies and lack of assessment or follow-up to achieve outcomes.</p> <p><strong>Conclusion:</strong> The results showed that telehealth and telemedicine could have advantages such as preventing the spread of COVID-19, reducing the healthcare burden, and maintaining appropriate patient care. In addition to these benefits, several limitations and obstacles, including organizational, technological, and patient-related barriers, may be encountered, so it is better to consider the necessary arrangements before implementing telemedicine.</p> Reza Safdari, Marsa Gholamzadeh, Sorayya Rezayi, Mozhgan Tanhapour, Soheila Saeedi Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/1150 Tue, 14 Sep 2021 00:00:00 +0430 Evaluation the preventive effect of Selenium on acute kidney injury following on-pump cardiac surgery https://ircmj.com/index.php/IRCMJ/article/view/377 <p><strong><em>Introduction: </em></strong><em>patients who undergo on-pump cardiac surgery are at risk of acute kidney injury following the operation. This is mainly due to some ischemic events and also pre- and postoperative stress responses which can result in postoperative organ dysfunction. Selenium as an antioxidant may help to reduce the inflammation and subsequent related complications. In this study we tested that if administration of oral Se compliment before and following the on-pump cardiac surgery can reduce the incidence or severity of kidney injury following the operation.</em></p> <p><strong><em>Methods: </em></strong><em>In a randomized double-blind trial we divided the randomly selected patients who were candidate for on-pupm cardiac surgery into two groups of those who received selenium and control group. In selenium group we administrated 500 µg of selenium orally 14 and 2 hours before surgery and every 12 hours postoperatively for 2 days (overall 3000 µg) while the control group received only the routine and standard care. Subsequently patients were closely observed for serum creatinine rise and incidence of post-operative AKI during their hospitalization period in both groups using both Rifle and AKIN criteria separately. Besides, some additional data including: ICU-stay, duration of the operation and need for Blood products during the operation were recorded. At the end, the statistical analysis was carried out using SPSS 11.5 software in order to determine any significant difference in case and control group. </em></p> <p><strong><em>Results: </em></strong><em>The&nbsp;&nbsp;&nbsp; study&nbsp;&nbsp;&nbsp; population included 120 patients divided in two equal groups of 60, consisting of 46 (38.3%) males and 74 (61.7%) females with the mean age of&nbsp;&nbsp; 52.8±16.7 years. Both groups were similar regarding the demographics and comorbidities. Also statistics showed no significant difference regarding Cardiac&nbsp;&nbsp; Operative&nbsp;&nbsp; Risk Evaluation&nbsp;&nbsp; (EuroSCORE) in both groups. Considering the RIFLR criteria, AKI&nbsp;&nbsp;&nbsp; occurred&nbsp; &nbsp;in 11 (17.9%) patients in selenium group and 13 (21.4%) patients in control group while based on AKIN criteria figures were&nbsp; 17 (28.6%) and 21 (35.7%)&nbsp; in&nbsp; selenium and the control group , respectively. The most frequent stage of AKI among patients was the first stage in both group and the highest rate of AKI occurred in 3-4 days after surgery in both groups. </em></p> <p><strong><em>Conclusion: </em></strong><em>According to our research Administrating oral Selenium was not beneficial in order to prevent AKI after on-pump cardiac surgery. </em></p> Abbasali Zeraati, Shahram Amini, katayoun samadi, Hasan Mortazi, Mohammad Samadi, Tina Zeraati, Dorsa Zeraati Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/377 Tue, 14 Sep 2021 00:00:00 +0430 Relationship between creatine kinase and major bleeding in patients with non-ST-segment elevation acute coronary syndrome https://ircmj.com/index.php/IRCMJ/article/view/741 <p><strong>Objective:</strong> To investigate the relationship between creatine kinase (CK) and major bleeding in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients during hospitalization, and to analyze the predictive value of CK for major bleeding in NSTE-ACS patients during treatment.</p> <p><strong>Methods: </strong>A total of 1469 NSTE-ACS patients admitted to our hospital from January 2017 to December 2019 were collected, including 1024 unstable angina pectoris patients and 445 non-ST-segment elevation myocardial infarction patients. Plasma CK and hemoglobin concentrations were measured after admission. The patients were divided into major bleeding group (n=31) and non-major bleeding group (n=1438) according to Thrombolysis In Myocardial Ischemia bleeding classification standard, and they were given routine treatment.</p> <p><strong>Results:</strong> During the treatment period, major bleeding occurred in 31 of 1469 NSTE-ACS patients, accounting for 2.11%. CK value in major bleeding group was higher than that in non-major bleeding group (P&lt;0.001). According to the quartile, CK was divided into groups Q1-Q4, and the incidence of major bleeding in group Q4 was higher than that of the other three groups (P&lt;0.001). Plasma CK was positively correlated with major bleeding in NSTE-ACS patients (r=0.59, P&lt;0.001). Receiver operating characteristic curve analysis showed that the area under the curve of baseline CK value was 0.793 (SE=0.062, P=0.001, 95%CI 0.711-0.872) in NSTE-ACS patients during treatment.</p> <p><strong>Conclusion:</strong> CK was associated with major bleeding in NSTE-ACS patients.</p> Junran Zhang, Kaiyan Shao, Shuguo Yang, Qinghua Ma Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/741 Tue, 14 Sep 2021 00:00:00 +0430 Preprocedural intravenous Ibuprofen for post-repair pain relief after traumatic wound management: A randomized Clinical Trial https://ircmj.com/index.php/IRCMJ/article/view/783 <p>Introduction: Wound repair may cause extra pain and inflammation leading to post-repair discomfort. Previous studies showed that Pre-operative use of NSAIDs may reduce pain after surgery but data on traumatic wound repair are lacking.</p> <p>Methods: This is a double-blind randomized controlled trial. Based on inclusion and exclusion criteria, 194 participants were randomly assigned to either intervention or control groups. In the intervention group Ibuprofen 800 mg in 100 cc normal saline infused before wound repair while the control group received 100 cc normal saline. Numeric pain scores were recorded at the beginning of wound repair and 30 minutes after that. Patients’ satisfaction with analgesia was also recorded 15 minutes after drug infusion, during wound repair, and 6 hours after wound repair.</p> <p>Results: Mean pain scores during wound repair, before local anesthesia with lidocaine, were similar in both groups mean pain score 30 minutes after the repair was significantly lower in patients who received Ibuprofen, 3.86±1.93 vs 4.46±1.89 (p=0.043). Patients’ satisfaction with pain management 6 hours after wound repair was higher in the intervention group (p=0.000).</p> <p>Conclusion: use of IV Ibuprofen before wound repair can reduce pain score after repair and is accompanied by improved patients’ satisfaction.</p> Hossein Shaker, Mohammad Hossein Rezaei, Hamed Basir Ghafouri, Niloofar Abazarian, Ehsan Modirian Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/783 Tue, 14 Sep 2021 00:00:00 +0430 Management of Combined Orthopedic and Vascular Traumas https://ircmj.com/index.php/IRCMJ/article/view/751 <p><strong>Background &amp; Objectives</strong>: Orthopedic trauma and vascular trauma are the cases that can be seen clinically and can have negative consequences if not intervened appropirately<strong>. </strong>In this study, we presented our clinical experiences regarding vascular traumas in combination with extremity fractures or dislocations.</p> <p><strong>Methods</strong>: Between November 2012 and February 2020, a total of 95 patients (78 male, 17 female, and mean age 34.7 ± 5.6 years) who underwent a surgical treatment for combined orthopedic and vascular trauma were included in the study. Patients were retrospectively evaluated according to their clinical properties, while the treatment strategies and the results were performed.</p> <p><strong>Results</strong>: Traffic accidents were the most common reason of the trauma with the rate of 36.8% (n=35). The most common orthopedic injury was seen in femur, whereas the most common vascular injury was on superficial femoral artery. The most commonly performed vascular treatment method was primary repair, and orthopedic treatment was external fixation. Mortality rate was 2.1% (n=2) and amputation rate was 15.7% (n=15).</p> <p><strong>Conclusion</strong>: Combined orthopedic vascular traumas are seen less frequently than isolated vascular traumas, but mortality and amputation rates are higher. In order to decrease mortality and amputation rates, communication should be perfectly coordinated between the emergency department and orthopedic and cardiovascular surgery clinics and urgent intervention is crucial.</p> Yüksel Dereli, Özgür Altınbaş, Mehmet Işık, Ömer Tanyeli, Serkan Yıldırım, İsmail Hakkı Korucu, Volkan Burak Taban, Niyazi Görmüş Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/751 Tue, 14 Sep 2021 00:00:00 +0430 Risk Factors for Mortality in Hospitalized Patients with COVID-19, Southwestern of Iran; a cross-sectional study https://ircmj.com/index.php/IRCMJ/article/view/1230 <p><strong>Background</strong>:</p> <p><strong>Coronavirus disease 2019 (COVID-19) has become a global health challenge with high transmission and mortality rates. This study aimed to identify prognosis factors of the risk of death among hospitalized patients with COVID-19 in Behbahan City, southwest of Iran.</strong></p> <p><strong>Methods:</strong></p> <p><strong>&nbsp;In this study, information of 800 patients with COVID-19 admitted to Shahidzadeh Hospital in Behbahan City southwest of Iran from March 20, 2020, to Jan 20, 2021, was investigated. Thereafter, the demographic information, clinical symptoms, vital signs, pharmacotherapy, Laboratory findings and the patients' underlying diseases were extracted and then recorded from their medical records. Cox regression with PH assumption was used to investigate the risk factors of death.</strong></p> <p><strong>Results: </strong></p> <p><strong>The present study included 800 patients with Covid-19 with a mean age of 57.51 ± 16.83 years old at the time of diagnosis. Accordingly, the studied sample consisted of 447 (55.8%) male and 353 (44.1%) female patients. Based on the Cox regression analysis, age variables (HR=1.04; 95% CI: 1.03-1.05; P&lt;0.001), Cardiovascular Disease (HR=2.46; 95% CI: 1.63- 3.70; P&lt;0.001), and renal failure (HR=2.77; 95% CI: 1.43- 534; P&lt;0.001) were found to be associated with the death risk in patients with COVID-19.</strong></p> <p><strong>Discussion: </strong></p> <p><strong>According to the findings of this study, the patient's age at the time of diagnosis, cardiovascular disease, and renal failure were indicated to be the main prognostic factors of high mortality rate in patients with COVID-19. Identifying these risk factors can be helpful in the timely intervention of patients at high risk of death for health care providers.</strong></p> Alireza Ahmadi, Soroush Ardeshiri, Vahid Rajab Nezhadi, Aida Pajoohesh, Touba Narimani Moghadam, Mohamad Sabaghan, Jaffar Fatahi Asl , Javad Zarei, Kambiz Ahmadi Angali Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/1230 Tue, 14 Sep 2021 00:00:00 +0430 Does Being a Refugee Increase the Possibility of Complicated Appendicitis? https://ircmj.com/index.php/IRCMJ/article/view/833 <p><strong>Background</strong><strong>; </strong>Refugees may have problems in recognizing their illnesses and accessing treatment due to communication and sociocultural factors.</p> <p><strong>Objective</strong><strong>s;</strong> In this study, we aimed to present whether there is a difference in complicated appendicitis rates between Turkish and refugee patients.</p> <p><strong>Methods;</strong> A total of 563 patients who underwent appendectomy surgery in our hospital between September 2018 and June 2020 and met the study criteria were examined. The patients were divided into two groups. Group-1 constituted of the Turkish patients, and Group-2 constituted of the refugee patients. The demographic, clinical, and histopathological characteristics of the patients were compared.&nbsp;&nbsp;&nbsp;</p> <p><strong>Results;</strong> Group-1 had 489 (86.9%) patients, while Group-2 constituted of 74 (13.1%) patients. There were 278 (56.9%) male patients in Group-1 and 36 (48.6%) male patients in Group-2. Turkish patients' median age was 28 (18-81), while the median age of refugee patients was 27 (18-75). Intraoperative perforation detection ratio, open appendectomy ratio, preoperative C-reactive protein level, histopathological gangrenous or perforated appendicitis ratio and postoperative hospital stay length were found higher in the refugee patient group (p&lt;0.05).</p> <p><strong>Conclusion;</strong> Refugee patients are intense in countries such as Turkey; We believe that general surgery specialists should consider the possibility of complicated appendicitis in refugee patients scheduled for surgery for acute appendicitis.</p> Durmuş Ali Çetin, Mehmet Patmano, Tufan Gümüş, Hasan Elkan Copyright (c) 2021 Iranian Red Crescent Medical Journal https://ircmj.com/index.php/IRCMJ/article/view/833 Tue, 14 Sep 2021 00:00:00 +0430